Rheumatology

Genetic and immunological research in a patient with an unknown inflammatory disease in adulthood has given a unique insight in the origin of this type of disorders. The findings were the start of a successful initiation of targeted therapy in the patient.

UZ Leuven researchers have shown that a combination therapy of methotrexate and cortisone is the optimal start treatment for patients with early rheumatoid arthritis, regardless of the severity of their prognosis. These are the results from a 5 year trial in various Flemish rheumatology centres.